Arbutus Biopharma Corporation logo

ABUSArbutus Biopharma Corporation

ABUS Stock Price, Valuation & Chart | Arbutus Biopharma Corporation

Compare

ABUS Historical price chart

ABUS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.01B
PE Ratio6.14
EPS0.83
Trading Volume2.97M
Today's High/Low5.19/5.09
Dividend Yield0.00
52 Week High/Low5.45/3.5
Shares Outstanding197.54M
ABUS Financial Statement
ABUS Analyst ratings
ABUS Analysis & performance metrics

ABUS Company profile

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in…

ABUS Management team

Management
R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C.
Corporate Secretary
Lindsay Androski J.D., M.B.A.CEO
President, Chief Executive Officer & Chairman
Andrew J. Sung
General Counsel
Tuan NguyenCFO
Chief Financial Officer
Shannon Briscoe SPHR
Vice President of Human Resources
Total 5 executives

ABUS Frequently asked questions

What is Arbutus Biopharma Corporation (ABUS) Stock Price?

Current stock price of Arbutus Biopharma Corporation (ABUS) stock is $5.100. The stock price is +0.20% higher in the session. The intraday range can be seen from this page. Volume of Arbutus Biopharma Corporation (ABUS) stock is 2.97M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Arbutus Biopharma Corporation (ABUS) stock price going up or down today?

The stock price of Arbutus Biopharma Corporation (ABUS) can change with earnings, company news, and overall market sentiment. Arbutus Biopharma Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Arbutus Biopharma Corporation stock expensive at its current price?

Whether Arbutus Biopharma Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABUS on this page is 6.14. EPS on this page is 0.83. Compare those figures with peers and growth expectations before deciding if the current Arbutus Biopharma Corporation price is justified.

How has the stock price of Arbutus Biopharma Corporation (ABUS) performed historically?

Historical performance for Arbutus Biopharma Corporation (ABUS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABUS reacted to past earnings and market events.

Should I buy Arbutus Biopharma Corporation (ABUS) stock, at this price?

Buying Arbutus Biopharma Corporation (ABUS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.